No Data
No Data
Part 2 of the previous day's moving stocks include Shin-Toh, Japan Casting, Grid, etc.
Stock name <Code> 4th closing price ⇒ Day-to-day comparison Kagurazaka Capital<3498> 15690 -850 The supply-demand factors centered on short-term funds are believed to be leading. Tsukuba Bank<8338> 321 -20 The decline in long-term interest rates softened bank stocks. Tohoku Electric Power<9506> 1486.5 -56.5 Electricity stocks are all down. Fuji Petroleum<5017> 509 -25 Seen as negative material for the decline in crude oil market conditions. Hokuhoku<8377> 2187 -134 A selling point for the decline in long-term interest rates in Japan and the United States.
Active and newly listed stocks during the morning session.
*Eiwa En HD <2899> 2740 K -The TOB price is expected to be 3100 yen due to MBO announcement. *Media's HD <3154> 990 +115 upward revision of performance and dividend estimates. *Maas GH <6419> 3775 +335 it was revealed that Takateru Murakami has emerged as a major shareholder. *SHIFT <3697> 16545 +1285 small and medium-sized growth stocks are strong overall due to the decrease in long-term US interest rates. *Medley <4480> 3590 +240 subsidiary companies are Ubicom.
Steady, supported by a low long-term US Treasury yield.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a firm trend. In yesterday's US stock market on the 3rd, the Dow Jones average fell 115.29 dollars (-0.30%) to 38,571.03 dollars. The unexpected decline in the May ISM Manufacturing Conditions Index and the fall in payment prices spread expectations of interest rate cuts, which supported stock prices. On the other hand, concerns about economic slowdown have emerged, weighing on stock prices. The Nasdaq remained firmly supported by semiconductor Nvidia's recovery and buying on expectations of a further decline in interest rates for gold.
CHIOME BIOSCIENCE: Confirmation
CHIOME BIOSCIENCE: Quarterly Report - 21st Quarter 1st Quarter (2024/01/01 - 2024/03/31)
Chiome Bioscience 1Q Parent Loss Y304.00M Vs Loss Y227.00M
Chiome Bioscience Inc. (4583.TO) Japan 1st Quarter Ended March 31 PARENT 2024 2023 Revenue Y129.00 mln Y169.00 mln Operating Profit (Y
No Data